Prostate cancer patients whose cancer has not improved through chemotherapy may have a new, more effective medication alternative.

A common treatment for prostate cancer is radiation therapy. Traditional radiation therapy can harm healthy tissue and result in harmful side effects. A new radiation therapy offers patients a better alternative.

Standard radiation for treating cancer usually lasts a matter of weeks. Researchers are now finding that shortening that time has long-lasting benefits for prostate cancer patients.

There's been a great deal of debate about if and/or how to treat men in their mid-70s who have prostate cancer. A new study shows that doctors are either under- or over-treating the disease in this age group.

The treatment options for advanced prostate cancer that's spread to the bone are minimal at this point. An experimental drug that's currently being tested may soon change the outlook for patients.

Prostate cancer treatment typically interferes with sexual function. It's to be expected. Now, doctors have a way of predicting when normal sexual activity will resume.

Imagine having a tiny light implanted in your body that could signal when cancer appears. Just such an invention may be just around the corner.

Prostate cancer cases and deaths are more common in African-American men than in white men, and scientists have recently identified what's behind this disparity.

September is prostate cancer awareness month, and the latest statistics of new cases have been released by the Centers for Disease Control and Prevention (CDC).

Some forms of prostate cancer don't respond to any available therapies. An investigational compound currently being studied in clinical trials may soon change that.